Partner Therapeutics Competitors and Similar CompaniesClear all

Partner Therapeutics's competitors and similar companies include Halozyme Therapeutics, OS Therapies, Andarix Pharmaceuticals and OncoHost.
Partner Therapeutics
Partner Therapeutics
Partner Therapeutics is developing and commercializing cancer medicines and combination therapies.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
OS Therapies
OS Therapies
OS Therapies (OST) is a therapeutic company focused on the identification, development and commercialization of treatments for osteosarcoma.
Andarix Pharmaceuticals
Andarix Pharmaceuticals
Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.
OncoHost
OncoHost
OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies.
Founding Date
Founding Date
2017
Founding Date
1998
Founding Date
2017
Founding Date
N/A
Founding Date
2017
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Lexington, US HQ
Boston, US
Lynnwood, US
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Locations
HQ
Locations
Binyamina-Giv'at Ada, IL HQ
Employees
Employees
2051% decrease
Employees
1457% increase
Employees
420% decrease
Employees
N/A
Employees
492% decrease
Twitter followers
Twitter followers
147
Twitter followers
423
Twitter followers
N/A
Twitter followers
27
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
1.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Employee Rating
Employee Rating
4.4
Employee Rating
3.1
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 60m (about 6 years ago)
Latest funding round
N/A
Latest funding round
$ 6m (almost 3 years ago)
Latest funding round
N/A
Latest funding round
$ 35m (almost 2 years ago)
Total funding raised
Total funding raised
$ 60m
Total funding raised
$ 171.9m
Total funding raised
$ 6m
Total funding raised
N/A
Total funding raised
$ 43m
For sources of this data, please see the company profile

View Company Profiles

Halozyme Therapeutics
HQ
San Diego, US
Employees
145↑ 7% increase

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company
OS Therapies
HQ
Cambridge, US
Employees
4↓ 20% decrease

OS Therapies (OST) is a therapeutic company focused on the identification, development and commercialization of treatments for osteosarcoma.

View company
Andarix Pharmaceuticals
HQ

Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.

View company
OncoHost
HQ
Binyamina-Giv'at Ada, IL
Employees
49↓ 2% decrease

OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies.

View company